Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
From Launch to Leadership: Mounjaro Crosses Rs 333 Crore, Becomes India’s Top-Selling Drug We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Tamil Nadu-based Sresan Pharmaceuticals‘ cough syrup brand Coldrif that allegedly caused the deaths of more than 20 children in Madhya Pradesh is among thousands of generic cough syrup brands currently available in the domestic market, thriving below the regulatory radar. In less than a fortnight, cough syrups from at least three companies Sresan, Rednex and…
Mumbai: Eli Lilly‘s breakthrough weight-loss and diabetes drug Mounjaro has stunned the Indian pharmaceutical market, rising to the no. 2 position in sales within six months of its launch – a feat rarely seen in recent pharma history. Mounjaro posted sales of ₹80 crore in September, closely trailing the legacy antibiotic brand Augmentin (₹85 crore)…
New Delhi: The GST rate cuts announced last week will make medicines used for the treatment of critical conditions like multiple myeloma, lung cancer, blood cancer, lymphoma, Gaucher disease, Pompe disease and haemophilia significantly cheaper and help more patients to avail of treatment, health experts said. A pack of leukaemia drug asciminib 60 (40 mg…